Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-18

FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals' supplemental ANDA for memantine hydrochloride, a generic memantine product for the treatment of symptoms of Alzheimer's dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

SUPPL AP for MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)